Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 10, 2026 1 hour, 41 minutes ago
Medical News: Researchers from Scripps Health’s Shiley Center for Orthopaedic Research and Education at Scripps Clinic in La Jolla, California, have unveiled promising new findings that could reshape how osteoarthritis is treated. Their work focuses not on stem cells themselves, but on the powerful healing substances those cells release, known as the “secretome.” This
Medical News report explores how these tiny biological packages may protect damaged joints and reduce inflammation without the need for direct cell transplantation.
Lab-produced stem cell secretome dramatically protects damaged cartilage and stabilizes blood vessel networks
in osteoarthritis models
What Is the Stem Cell Secretome?
Mesenchymal stem cells, or MSCs, are well known for their regenerative abilities. However, scientists are increasingly discovering that much of their healing power comes from the substances they secrete. This mixture, called the secretome, contains growth factors, proteins, and microscopic particles known as extracellular vesicles.
In this study, researchers examined secretomes derived from two types of stem cells: human embryonic stem cell–derived mesenchymal stem cells and mesenchymal stem cells isolated from infrapatellar fat pad tissue taken from osteoarthritis patients undergoing knee replacement surgery. All cells were grown in carefully controlled, animal-free laboratory conditions to ensure clinical relevance.
On average, the secretome preparations contained roughly 50 billion microscopic vesicles per milliliter. These vesicles ranged mostly between 50 and 200 nanometers in size and carried important surface markers confirming their identity.
Boosting Cell Growth and Blood Vessel Formation
One of the most striking findings was the secretome’s ability to stimulate cell growth. When applied to stem cells in laboratory tests, both the concentrated conditioned medium and purified vesicles significantly increased cell proliferation. The effect was dose-dependent, meaning higher concentrations produced stronger responses.
The researchers also examined how the secretome influenced blood vessel formation. Healthy blood supply is critical for tissue repair. In laboratory models using human endothelial cells embedded in fibrin gels, untreated vessel-like networks initially formed but collapsed by day seven. However, when treated with secretome collected from stem cells grown under low oxygen conditions, the vascular networks remained stable and intact. Measurements showed significant increases in total network length, branching, and structural complexity.
This suggests that oxygen-conditioned stem cell secretome may help preserve and stabilize blood vessels in damaged tissues.
Protecting Osteoarthritic Cartilage
Perhaps most importantly, the study demonstrated powerful anti-inflammatory and cartilage-protective effects in human osteoarthritis tissue samples. Cartilage explants taken from knee rep
lacement patients were exposed to an inflammatory molecule called IL-1β, which normally triggers cartilage breakdown.
Within days, untreated samples showed increased release of glycosaminoglycans, key components of cartilage structure, indicating tissue degradation. However, treatment with the stem cell secretome reduced this destructive release significantly. Concentrated secretome treatment reduced glycosaminoglycan loss by nearly threefold in inflamed samples. Purified vesicles also produced meaningful reductions.
Gene analysis revealed that inflammatory and cartilage-degrading genes such as IL-1β, MMP-1, and MMP-3 were reduced by two- to six-fold following treatment. These genes are directly linked to cartilage destruction in osteoarthritis. Notably, the secretome did not cause unwanted genetic changes in healthy cartilage samples.
A Safer Cell-Free Therapy
Unlike traditional stem cell injections, secretome-based therapy does not involve transplanting living cells. This greatly reduces potential risks such as immune rejection or tumor formation. The researchers emphasize that their scalable production method allows for consistent and reproducible manufacturing, a key step toward clinical use.
Conclusion
The findings demonstrate that stem cell–derived secretomes can stimulate cell growth, stabilize blood vessel networks, and significantly reduce cartilage degradation in human osteoarthritis tissue. By targeting both inflammation and tissue breakdown pathways, this approach may offer a disease-modifying treatment rather than simply masking symptoms. Although further studies, including larger donor samples and animal trials, are needed before human use, the data strongly support secretome therapy as a promising, safer alternative to direct stem cell transplantation for joint diseases and other inflammatory conditions.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/5/2325
For the latest on stem cell therapies, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/stem-cell-therapies
Share
Tweet
Share
